
Bruno Larvol/X
May 11, 2025, 14:04
Bruno Larvol Highlights Most Discussed Trials on X Using Larvol CLIN Platform
Bruno Larvol, CEO of LARVOL, posted on X:
“Most discussed trials (by drugs) on X by Vinay Prasad vs Stephen V Liu as measured by the Larvol CLIN platform.
I respect both Drs Liu and Prasad. Do you feel such analytics is useful or not?”
More posts featuring Larvol.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 11, 2025, 14:04
May 11, 2025, 13:56
May 11, 2025, 13:29
May 11, 2025, 11:55